• Home
  • About
  • Stock Information
  • SEC Filings
  • Analyst Coverage
  • Corporate Governance
  • Backgrounders
  • Images
  • Technology
  • Pipeline
  • Partnering
  • Privacy Policy
  • Terms and Conditions of Use
  • Newsletters
  • Pipeline

    Since our founding, Agenus has pursued our principles of targeting the immune system to fight disease. Tumors evade detection and elimination by the immune system through various mechanisms. We are using multiple strategies, as monotherapies as well as combinations, to harness the immune system to fight cancer. We are deploying our expertise and insights into immune and cancer biology to find the right combinations of checkpoint modulating antibodies, tumor microenvironment (TME) modulators, cancer vaccines, adjuvants and adoptive cell therapy.